SMARCA5 and anemia: Loss of SMARCA5 abrogates definitive hematopoiesis within the fetal liver and leads to anemia and embryonic lethality at day 18.5.[25] The interaction between molnc‐301b and SMARCA5 were validated through RNA pull‐down assays (Figure 4F).